1-5 of 5
David Erlinge
Close
Sort by
Journal Articles

The first specific antiplatelet antidote

David Erlinge
Journal: Blood
Blood (2015) 125 (22): 3372–3374.
https://doi.org/10.1182/blood-2015-04-636274
Published: 2015
Journal Articles

Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression

Olof Gidlöf, Marcel van der Brug, Jenny Öhman, Patrik Gilje, Björn Olde, Claes Wahlestedt, David Erlinge
Journal: Blood
Blood (2013) 121 (19): 3908–3917.
https://doi.org/10.1182/blood-2012-10-461798
Published: 2013
Includes: Supplemental data
Journal Articles

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease

Christian Lood, Stefan Amisten, Birgitta Gullstrand, Andreas Jönsen, Maria Allhorn, Lennart Truedsson, Gunnar Sturfelt, David Erlinge, Anders A. Bengtsson
Journal: Blood
Blood (2010) 116 (11): 1951–1957.
https://doi.org/10.1182/blood-2010-03-274605
Published: 2010
Includes: Supplemental data
Journal Articles

Platelets synthesize large amounts of active plasminogen activator inhibitor 1

Helén Brogren, Lena Karlsson, Maria Andersson, Lingwei Wang, David Erlinge, Sverker Jern
Journal: Blood
Blood (2004) 104 (13): 3943–3948.
https://doi.org/10.1182/blood-2004-04-1439
Published: 2004
Journal Articles

ATP Release from Red Blood Cells Is Regulated by a Negative Feedback Pathway where ADP Acts on P2Y 13 Receptors.

Martin L. Olsson, MD, PhD, Lingwei Wang, MD, PhD, Goran Olivecrona, MD, Matthias Gotberg, MD, Stefan Amisten, MSc, PhD, Maria Sorhede Winzell, PhD, David Erlinge, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1576.
https://doi.org/10.1182/blood.V104.11.1576.1576
Published: 2004